{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:54:11Z","timestamp":1791003251148,"version":"4.1.0"},"reference-count":34,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2026,9,30]]},"DOI":"10.7883\/yoken.jjid.2026.105","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:16:06Z","timestamp":1790720166000},"source":"Crossref","is-referenced-by-count":0,"title":["Development of novel human monoclonal antibodies for botulinum neurotoxin type F subtype 1"],"prefix":"10.7883","author":[{"given":"Ayuha","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Laboratories of Veterinary Epidemiology, Graduate school of Veterinary Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Tarumizu","sequence":"additional","affiliation":[{"name":"Laboratories of Veterinary Epidemiology, Graduate school of Veterinary Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Veterinary Anatomy, Graduate school of Veterinary Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Katahira","sequence":"additional","affiliation":[{"name":"Laboratory of Pathopharmacology, Graduate school of Drug Discovery Sciences, Osaka Metropolitan University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kohda","sequence":"additional","affiliation":[{"name":"Laboratories of Veterinary Epidemiology, Graduate school of Veterinary Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol. 2014; 12:535\u201349.","DOI":"10.1038\/nrmicro3295"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rossetto O, Montecucco C. Tables of Toxicity of Botulinum and Tetanus Neurotoxins. Toxins. 2019; 11:686.","DOI":"10.3390\/toxins11120686"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gupta A, Sumner CJ, Castor M, et al. Adult botulism type F in the United States, 1981\u20132002. Neurology. 2005; 65:1694\u2013700.","DOI":"10.1212\/01.wnl.0000187127.92446.4c"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Meurens F, Carlin F, Federighi M, et al. <i>Clostridium botulinum<\/i> type C, D, C\/D, and D\/C: An update. Front Microbiol. 2023;13.","DOI":"10.3389\/fmicb.2022.1099184"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Raphael BH, Choudoir MJ, L\u00faquez C, et al. Sequence diversity of genes encoding botulinum neurotoxin type F. Appl Environ Microbiol. 2010; 76:4805\u201312.","DOI":"10.1128\/AEM.03109-09"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Peck MW, Smith TJ, Anniballi F, et al. Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature. Toxins. 2017; 9:38.","DOI":"10.3390\/toxins9010038"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kohda T, Nakamura K, Hosomi K, et al. Characterization of the functional activity of botulinum neurotoxin subtype B6. Microbiol Immunol. 2017; 61:482\u20139.","DOI":"10.1111\/1348-0421.12540"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kohda T, Tsukamoto K, Torii Y, et al. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells. Microbiol Immunol. 2020; 64:502\u201311.","DOI":"10.1111\/1348-0421.12796"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Torii Y, Goto Y, Nakahira S, et al. Comparison of the immunogenicity of botulinum toxin type A and the efficacy of A1 and A2 neurotoxins in animals with A1 toxin antibodies. Toxicon. 2014; 77:114\u201320.","DOI":"10.1016\/j.toxicon.2013.11.006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kammerer RA, Benoit RM. Botulinum neurotoxins: new questions arising from structural biology. Trends Biochem Sci. 2014; 39:517\u201326.","DOI":"10.1016\/j.tibs.2014.08.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Montecucco C. How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci. 1986; 11:314\u20137.","DOI":"10.1016\/0968-0004(86)90282-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dong M, Masuyer G, Stenmark P. Botulinum and Tetanus Neurotoxins. Annu Rev Biochem. 2019; 88:811\u201337.","DOI":"10.1146\/annurev-biochem-013118-111654"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Winner BM, Bodt SML, McNutt PM. Special Delivery: Potential Mechanisms of Botulinum Neurotoxin Uptake and Trafficking within Motor Nerve Terminals. Int J Mol Sci. 2020; 21:8715.","DOI":"10.3390\/ijms21228715"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Arnon SS. Creation and Development of the Public Service Orphan Drug Human Botulism Immune Globulin. Pediatrics. 2007; 119:785\u20139.","DOI":"10.1542\/peds.2006-0646"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Matsumura T, Amatsu S, Misaki R, Yutani M, Du A, Kohda T, et al. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B. Toxins. 2020; 12:302.","DOI":"10.3390\/toxins12050302"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fan Y, Garcia-Rodriguez C, Lou J, et al. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes. PLOS ONE. 2017; 12: e0174187.","DOI":"10.1371\/journal.pone.0174187"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nayak SU, Griffiss JM, McKenzie R, et al. Safety and Pharmacokinetics of XOMA 3AB, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin A. Antimicrob Agents Chemother. 2014; 58:5047\u201353.","DOI":"10.1128\/AAC.02830-14"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mukamoto M, Maeda H, Kohda T, et al. Production of a Neutralizing Mouse-Human Chimeric Antibody against Botulinum Neurotoxin Serotype E. Jpn J Infect Dis. 2013; 66:46\u201350.","DOI":"10.7883\/yoken.66.46"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhao H, Nakamura K, Kohda T, et al. Characterization of the Monoclonal Antibody Response to Botulinum Neurotoxin Type A in the Complexed and Uncomplexed Forms. Jpn J Infect Dis. 2012; 65:138\u201345.","DOI":"10.7883\/yoken.65.138"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Przedpelski A, Tepp WH, Zuverink M, et al. Enhancing toxin-based vaccines against botulism. Vaccine. 2018; 36:827\u201332.","DOI":"10.1016\/j.vaccine.2017.12.064"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yu YZ, Li N, Wang RL, et al. Evaluation of a Recombinant Hc of Clostridium botulinum Neurotoxin Serotype F as an Effective Subunit Vaccine. Clin Vaccine Immunol. 2008; 15:1819\u201323.","DOI":"10.1128\/CVI.00239-08"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chen C, Wang S, Wang H, et al. Potent Neutralization of Botulinum Neurotoxin\/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain. PLOS ONE. 2012; 7: e43845.","DOI":"10.1371\/journal.pone.0043845"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Li Z, Lu J, Tan X, et al. Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E. Toxins. 2022; 14:135.","DOI":"10.3390\/toxins14020135"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Li Z, Li B, Lu J, et al. Biological and Immunological Characterization of a Functional L-HN Derivative of Botulinum Neurotoxin Serotype F. Toxins. 2023; 15:200.","DOI":"10.3390\/toxins15030200"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Satofuka H, Abe S, Moriwaki T, et al. Efficient human-like antibody repertoire and hybridoma production in trans-chromosomic mice carrying megabase-sized human immunoglobulin loci. Nat Commun. 2022; 13:1841.","DOI":"10.1038\/s41467-022-29421-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kozaki S, Oga Y, Kamata Y, et al. Activation of <i>Clostridium botulinum<\/i> type B and E derivative toxins with lysine-specific proteases. FEMS Microbiol Lett. 1985; 27:149\u201354.","DOI":"10.1111\/j.1574-6968.1985.tb00658.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kondo H, Shimizu T, Kubonoya M, et al. Titration of Botulinum Toxins for Lethal Toxicity by Intravenous Injection into Mice. Jpn J Med Sci Biol. 1984; 37:131\u20135.","DOI":"10.7883\/yoken1952.37.131"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248\u201354.","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Subas Satish HP, Zeglinski K, Uren RT, et al. NAb-seq: an accurate, rapid, and cost-effective method for antibody long-read sequencing in hybridoma cell lines and single B cells. mAbs. 2022; 14:2106621.","DOI":"10.1080\/19420862.2022.2106621"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Inoue M, Tanida T, Kondo T, et al. Oxygen-glucose deprivation-induced glial cell reactivity in the rat primary neuron-glia co-culture. J Vet Med Sci. 2023; 85:799\u2013808.","DOI":"10.1292\/jvms.23-0175"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kohda T, Kamata Y, Kozaki S. Endocytosis of Clostridium botulinum Type B Neurotoxin into Rat Brain Synaptosomes. J Vet Med Sci. 2000; 62:1133\u20138.","DOI":"10.1292\/jvms.62.1133"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Zeninskaya NA, Ryabko AK, Marin MA, et al. Selection of Candidate Monoclonal Antibodies for Therapy of Botulinum Toxin Type A Intoxications. Toxins. 2024; 16:284.","DOI":"10.3390\/toxins16070284"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Garcia-Rodriguez C, Yan S, Geren IN, et al. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D. Toxins. 2021; 13:641.","DOI":"10.3390\/toxins13090641"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lam K ho, Tremblay JM, Vazquez-Cintron E, et al. Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins. Cell Rep. 2020; 30:2526-2539.e6.","DOI":"10.1016\/j.celrep.2020.01.107"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2026.105\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:34:23Z","timestamp":1791002063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2026.105\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2026.105","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"JJID.2026.105"}}